WallStreetZen

NYSE: MDT
Medtronic plc Stock

$131.65+1.07 (+0.82%)
Updated Sep 15, 2021
MDT Price
$131.65
Fair Value Price
N/A
Market Cap
$177.18B
52 Week Low
$98.94
52 Week High
$135.89
P/E
45.71x
P/B
3.44x
P/S
5.59x
PEG
1.35x
Dividend Yield
1.8%
Revenue
$31.60B
Earnings
$3.88B
Gross Margin
66.5%
Operating Margin
15.86%
Profit Margin
12.3%
Debt to Equity
0.78
Operating Cash Flow
$7B
Beta
0.89
Next Earnings
N/A
Ex-Dividend
Sep 23, 2021
Next Dividend
Oct 15, 2021

Zen Score

High
Medium
Low
50
Industry average

Reasons for this score

MDT ($131.65) is trading below its intrinsic value of $349.26, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US market average -8.74x)
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US Medical Devices industry average (51.49x)
Valuation

1 of 13

MDT News

Valuation

MDT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
45.71x
Industry
51.49x
Market
-8.74x
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US market average -8.74x)
Valuation
MDT is good value based on its earnings relative to its share price (45.71x), compared to the US Medical Devices industry average (51.49x)
Valuation

MDT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.44x
Industry
5.39x
MDT is good value based on its book value relative to its share price (3.44x), compared to the US Medical Devices industry average (5.39x)
Valuation

MDT price to earnings growth (PEG)

For valuing profitable companies with growth potential
MDT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.35x)
Valuation

MDT's financial health

Profit margin

Revenue
$8.0B
Net Income
$763.0M
Profit Margin
9.6%
MDT's Earnings (EBIT) of $5.01B can safely cover interest payments on company debt ($25.96B)
Financials
MDT's profit margin has decreased (-3.5%) in the last year from (15.8%) to (12.3%)
Financials

Assets to liabilities

Assets
$91.8B
Liabilities
$40.1B
Debt to equity
0.5
MDT's short-term assets ($22.43B) exceed its short-term liabilities ($7.76B)
Financials
MDT's long-term liabilities ($32.37B) exceed its short-term assets ($22.43B)
Financials
MDT's debt relative to shareholder equity (0.78) has decreased or remained constant compared to 5 years ago (0.94)
Financials
MDT's debt to equity ratio (0.78) is considered high
Financials

Cash flow

Operating
$1.3B
Investing
-$784.0M
Financing
-$1.1B
MDT's operating cash flow ($7.25B) is sufficient to service the company's debt ($25.96B)
Financials

Medtronic Stock FAQ

What is Medtronic's quote symbol?

(NYSE: MDT) Medtronic trades on the NYSE under the ticker symbol MDT. Medtronic stock quotes can also be displayed as NYSE: MDT.

What is the 52 week high and low for Medtronic (NYSE: MDT)?

(NYSE: MDT) Medtronic's 52-week high was $135.89, and its 52-week low was $98.94. It is currently -3.12% from its 52-week high and 33.06% from its 52-week low.

How much is Medtronic stock worth today?

(NYSE: MDT) Medtronic currently has 1,345,809,975 outstanding shares. With Medtronic stock trading at $131.65 per share, the total value of Medtronic stock (market capitalization) is $177.18B.

Medtronic stock was originally listed at a price of $26.25 in Dec 31, 1997. If you had invested in Medtronic stock at $26.25, your return over the last 23 years would have been 401.52%, for an annualized return of 7.26%.

How much is Medtronic's stock price per share?

(NYSE: MDT) Medtronic stock price per share is $131.65 today (as of Sep 15, 2021).

What is Medtronic's Market Cap?

(NYSE: MDT) Medtronic's market cap is $177.18B, as of Sep 16, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medtronic's market cap is calculated by multiplying MDT's current stock price of $131.65 by MDT's total outstanding shares of 1,345,809,975.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.